| Literature DB >> 35073842 |
Lei Tong1, Shao-Xing Dai2, De-Jun Kong1, Peng-Peng Yang2, Xin Tong2, Xiang-Rong Tong1, Xiao-Xu Bi1, Yuan Su1, Yu-Qi Zhao3, Zi-Chao Liu4.
Abstract
BACKGROUND: Leeches are classic annelids that have a huge diversity and are closely related to people, especially medicinal leeches. Medicinal leeches have been widely utilized in medicine based on the pharmacological activities of their bioactive ingredients. Comparative genomic study of these leeches enables us to understand the difference among medicinal leeches and other leeches and facilitates the discovery of bioactive ingredients.Entities:
Keywords: Bioactive Ingredients; Genome; Helobdella robusta; Hirudo medicinalis; Whitmania pigra
Mesh:
Year: 2022 PMID: 35073842 PMCID: PMC8787918 DOI: 10.1186/s12864-022-08290-5
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Genome annotation and evolution of W. pigra compared with H. robusta and H. medicinalis. A Phylogenetic analysis of leech species by Maximum Likelihood method based on COI genes. Highlighted with red dots correspond to three leech species compared with in our study. Posterior probabilities are assigned to the node; B the predicted protein-coding genes with matching entries in the three popular public databases; C the Venn diagram showed the orthologous genes between W. pigra and H. medicinalis (top panel), and between W. pigra and H. robusta (bottom panel); D Gene expansion and contraction in the W. pigra genome. The number of expanded (+) and contracted (-) gene families are shown along branches and nodes. E the Venn diagram showed the number of expanded and contracted gene families between W. pigra and H. medicinalis, and between W. pigra and H. robusta
Summary for genome sequencing, assembly and annotation
| Size of genome assembly | 228 Mbp | 177 Mbp | 187Mbp | 177Mbp |
| Num. of Scaffolds | 1,993 | 10,050 | 14,042 | 19,929 |
| Num. of scaffolds (> 2Kbp) | 1124 | 3495 | 5277 | 10128 |
| Scaffold N50 | 3,060 Kbp | 728 Kbp | 97 Kbp | 504Kbp |
| Total reads | 3,176,156 | 118,388,619 | 62,184,084 | NA |
| Reads mapping to genome (%) | 2,839,951 (89%) | 112,480,685 (95%) | NA | NA |
| Sequencing coverage depth | 7.92X | 100X | 73X | 146X |
| Repetitive content (%) | 33 | 23 | NA | 24 |
| GC (%) | 33 | 35 | 41 | 35 |
| Num. of predicted genes | 23,400 | 26,743 | 14,596 | 17205 |
| Protein length | 376 | 438 | 464 | NA |
| Mean exon length | 203 bp | 205 bp | 224 | NA |
| Mean intron length | 526 bp | 391 bp | 716 | NA |
| Mean number of exons per gene | 6.1 | 6.4 | 8 | NA |
Note: a The genome of H. robusta (Ref7), W. pigra (this study), H. medicinalis (Ref8), H. medicinalis (Ref9) were annotated using Genewise, BRAKER_v2, AUGUSTUS_v3 and MAKER_v2, respectively. NA, the data is not available in the references. GC, fraction of guanine plus cytosine nucleobases. Scaffold N50, the length such that half of the assembled sequence is in scaffolds longer than this length
Fig. 2Syntenic relationships between W. pigra and H. medicinalis, and between W. pigra and H. robusta. The top panel represents the syntenic relationships between W. pigra and H. medicinalis. The bottom panel shows the syntenic relationships between W. pigra and H. robusta. The scaffolds will be connected if they share similar genes. The width of link represents the number of shared genes
Fig. 3Enrichment analysis of expanded and contracted gene families between the three species using GO terms and interPro domains. GO terms (A) and interPro domains (B) were enriched by expanded gene families in W. pigra, H. medicinalis and H. robusta; GO terms (C) and interPro domains (D) were enriched by contracted gene families in W. pigra, H. medicinalis and H. robusta
Fig. 4Sequence analysis of the hirudin gene family. A Phylogenetic analysis of hirudin gene family from the species of family Hirudinidae. The tree was inferred by using the Maximum Likelihood method and JTT matrix-based model Likelihood method. B Multiple alignments of the amino acid sequences of hirudin proteins
Fig. 5Detailed analysis of hirudin genes and gene expression in W. pigra. A Genome-wide distribution of hirudin genes; B Gene structure of hirudin genes; C Jitter plot shown overall gene expression in W. pigra. D Gene expression of different classes of bioactive peptides
The exploration of five class of active substances in W. pigra, H. medicinalis and H. robusta
| Modes of action | Bioactive molecules | Gene copy | Gene copy | Gene copy |
|---|---|---|---|---|
| Analgesic and anti-inflammatory effect | Antistasin | 6 | 9 | 5 |
| Hirustasin | 0 | 18 | 7 | |
| Ghilanten | 9 | 10 | 7 | |
| Extracellular matrix degradation | Hyaluronidase | 1 | 4 | 5 |
| Inhibition of platelet function | Saratin | 1 | 4 | 1 |
| Anticoagulant effect | hirudin | 0 | 2 | 3 |
| Factor Xa inhibitor | 2 | 1 | 1 | |
| Therostasin | 5 | 4 | 2 | |
| Destabilase I a | 0 | 5 | 2 | |
| Antimicrobial effect | Destabilase I a | 0 | 5 | 2 |
| Total | 24 | 57 | 33 |
a Destabilase I, involved in anticoagulant effect and antimicrobial effect